Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Changchang Ge, Yi Lu, Hong Shen & Lei Zhu. (2022) Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scandinavian Journal of Gastroenterology 57:5, pages 513-524.
Read now
Read now
Articles from other publishers (10)
Boldizsár Jójárt, Tamás Resál, Diána Kata, Tünde Molnár, Péter Bacsur, Viktória Szabó, Árpád Varga, Kata Judit Szántó, Petra Pallagi, Imre Földesi, Tamás Molnár, József Maléth & Klaudia Farkas. (2024) Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 18:3, pages 392-405.
Crossref
Crossref
Zhenzhen Jia, Yujie Zhang, Chuanyu Zhang, Xueyong Wei & Mingzhen Zhang. (2023) Biosensing Intestinal Alkaline Phosphatase by Pregnancy Test Strips Based on Target-Triggered CRISPR-Cas12a Activity to Monitor Intestinal Inflammation. Analytical Chemistry 95:37, pages 14111-14118.
Crossref
Crossref
Roberta Vitali, Francesca Palone, Alessandro Armuzzi, Valerio Fulci, Anna Negroni, Claudia Carissimi, Salvatore Cucchiara & Laura Stronati. (2023) Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease. Journal of Crohn's and Colitis 17:1, pages 92-102.
Crossref
Crossref
Qianyi Zheng, Yongkang Chen, Yanping Zhai, Lin Meng, Han Liu, Haiyan Tian, Renyi Feng, Jiuqi Wang, Rui Zhang, Kedi Sun, Lina Gao, Yijing Wang, Xuejing Wang, Erxi Wu, Junfang Teng & Xuebing Ding. (2022) Gut Dysbiosis Is Associated With the Severity of Cryptogenic Stroke and Enhanced Systemic Inflammatory Response. Frontiers in Immunology 13.
Crossref
Crossref
Chenthan Krishnakumar, Ashwin N. Ananthakrishnan, Brendan M. Boyle, Anne M. Griffiths, Neal S. LeLeiko, David R. Mack, James F. Markowitz, Joel R. Rosh, Cary G. Sauer, Thomas D. Walters, Erin Bonkowski, Lee A. Denson, Jeffrey S. Hyams & Subra Kugathasan. (2021) Early Change in Fecal Calprotectin Predicts One‐Year Outcome in Children Newly Diagnosed With Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition 74:1, pages 72-78.
Crossref
Crossref
Aslı Aksu Çerman, Ezgi Aktaş Karabay, Hazel Ezgi Kaya, Filiz Türe Özdemir, Ezgi Özkur, Yasemin Erdem & İlknur Kıvanç Altunay. (2021) Evaluation of fecal calprotectin as a marker of gastrointestinal inflammation in rosacea: A case‐control study. Dermatologic Therapy 34:3.
Crossref
Crossref
Ana Cardeña Gutiérrez, Xabier Mielgo Rubio, Manuel Ruiz Muñoz, Ruth Martinez Cabañes, Diana Moreno Muñoz, Susana Hernando Polo, Clara Olier Garate, Alicia Hurtado Nuño, Verónica Sotelo Peña, Maria Virginia Sánchez Becerra, Andrea María González López, Mónica Esteban García, Teresa Robles Bermejo, Elia Pérez Fernández & Juan Carlos Cámara Vicario. (2021) Fecal calprotectin as a predictor of gastrointestinal immune-related adverse events (CF-19): A prospective study.. F1000Research 10, pages 534.
Crossref
Crossref
Tanmoy Rana. (2020) Unravelling of nitric oxide signalling: A potential biomarker with multifaceted complex mechanism associated with canine inflammatory bowel disease (IBD). Anaerobe 66, pages 102288.
Crossref
Crossref
James M. Gray, Kristin Knight, Vu Q. Nguyen, Marrieth G. Rubio, Lauren Irby, James H. Boone & Dario Sorrentino. (2020) Fecal Lactoferrin and Other Stool Markers during Normal Pregnancy and in Inflammatory Bowel Diseases: A Prospective Study and Review of the Literature. Inflammatory Intestinal Diseases 5:3, pages 151-158.
Crossref
Crossref
Robert H. Mills, Yoshiki Vázquez-Baeza, Qiyun Zhu, Lingjing Jiang, James Gaffney, Greg Humphrey, Larry Smarr, Rob Knight & David J. Gonzalez. (2019) Evaluating Metagenomic Prediction of the Metaproteome in a 4.5-Year Study of a Patient with Crohn's Disease. mSystems 4:1.
Crossref
Crossref